Anti-Human Integrin beta 2/CD18 & Integrin alpha L/CD11a Bispecific Reference Antibody (Rovelizumab, RUO)
Overview
| Catalog No. |
HY378026 |
| Brand |
abinScience |
| Species reactivity |
Human |
| Form |
Liquid |
| Storage buffer |
0.01M PBS pH 7.4 |
| Purity |
>95% as determined by SDS-PAGE. |
| Isotype |
IgG4-nd |
| Applications |
ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target |
Complement receptor C3 subunit beta, Cell surface adhesion glycoproteins LFA-1/CR3/p150, 95 subunit beta, Integrin beta-2, MFI7, CD18, ITGB2, CD11A, Leukocyte function-associated molecule 1 alpha chain, Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A, CD11 antigen-like family member A, CD11a, ITGAL, Integrin alpha-L, CR-3 alpha chain, Cell surface glycoprotein MAC-1 subunit alpha, Leukocyte adhesion receptor MO1, ITGAM, CD11b, CD11 antigen-like family member B, Integrin alpha-M, CR3A, CD11B, Neutrophil adherence receptor |
| Purification |
Protein A/G purified from cell culture supernatant. |
| Endotoxin level |
< 10 EU/mg |
| Expression system |
Mammalian cells |
| Accession |
P05107, P20701, P11215 |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | Bispecific, Hu23F2G, 23F2G, 339086-79-2 |
| Species |
Human |
| Note |
For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control |
Human IgG4 (S228P) Recombinant Isotype Control Antibody (13R4) (HP298207) |
Images
 SDS-PAGE |
SDS-PAGE for Research Grade Rovelizumab |